KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Depreciation & Amortization (CF): 2010-2015

Historic Depreciation & Amortization (CF) for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $43,000.

  • Biocryst Pharmaceuticals' Depreciation & Amortization (CF) rose 7.50% to $43,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $180,000, marking a year-over-year increase of 1.69%. This contributed to the annual value of $1.2 million for FY2024, which is 24.71% down from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Depreciation & Amortization (CF) stood at $43,000 for Q4 2015, which was down 0.00% from $43,000 recorded in Q3 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Depreciation & Amortization (CF) ranged from a high of $256,000 in Q4 2011 and a low of $40,000 during Q3 2014.
  • For the 3-year period, Biocryst Pharmaceuticals' Depreciation & Amortization (CF) averaged around $55,083, with its median value being $47,000 (2015).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 78.12% in 2011, then climbed by 11.36% in 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Depreciation & Amortization (CF) (Quarterly) stood at $256,000 in 2011, then crashed by 34.77% to $167,000 in 2012, then slumped by 65.87% to $57,000 in 2013, then declined by 29.82% to $40,000 in 2014, then increased by 7.50% to $43,000 in 2015.
  • Its Depreciation & Amortization (CF) stands at $43,000 for Q4 2015, versus $43,000 for Q3 2015 and $49,000 for Q2 2015.